https://www.zonebourse.com/cours/action/IPSEN-5137/actualite/Ipsen-La-Commission-europeenne-approuve-Cabometyx-avec-Opdivo-dans-le-cancer-du-rein-32845098/?utm_source=telegram&utm_medium=social&utm_campaign=share